![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Publisher: Adis International
ISSN: 1173-5503
Source: PharmacoEconomics and Outcomes News, Vol.1, Iss.519, 2007-01, pp. : 5-5
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Pioglitazone wins out over rosiglitazone in type 2 diabetes
Inpharma, Vol. 1, Iss. 1571, 2007-01 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
By Derosa G D'Angelo A Ragonesi PD Ciccarelli L Piccinni MN Pricolo F Salvadeo S Montagna L Gravina A Ferrari I Galli S Paniga S Cicero AFG
The Journal of International Medical Research, Vol. 34, Iss. 5, 2006-09 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Spotlight on pioglitazone in type 2 diabetes
Inpharma, Vol. 1, Iss. 1268, 2000-01 ,pp. :